- Home
- SID vs TMDX Comparison
SID vs TMDX Comparison
Compare SID & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SID
- TMDX
- Stock Information
- Founded
- SID 1941
- TMDX 1998
- Country
- SID Brazil
- TMDX United States
- Employees
- SID N/A
- TMDX N/A
- Industry
- SID Steel/Iron Ore
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SID Industrials
- TMDX Health Care
- Exchange
- SID Nasdaq
- TMDX Nasdaq
- Market Cap
- SID 2.0B
- TMDX 2.3B
- IPO Year
- SID 1997
- TMDX 2019
- Fundamental
- Price
- SID $1.45
- TMDX $66.66
- Analyst Decision
- SID Strong Sell
- TMDX Buy
- Analyst Count
- SID 3
- TMDX 10
- Target Price
- SID $2.40
- TMDX $118.44
- AVG Volume (30 Days)
- SID 2.6M
- TMDX 810.7K
- Earning Date
- SID 05-07-2025
- TMDX 04-29-2025
- Dividend Yield
- SID 14.01%
- TMDX N/A
- EPS Growth
- SID N/A
- TMDX N/A
- EPS
- SID N/A
- TMDX 1.01
- Revenue
- SID $7,063,567,739.00
- TMDX $441,540,000.00
- Revenue This Year
- SID $8.50
- TMDX $25.33
- Revenue Next Year
- SID $5.05
- TMDX $20.53
- P/E Ratio
- SID N/A
- TMDX $70.26
- Revenue Growth
- SID N/A
- TMDX 82.74
- 52 Week Low
- SID $1.27
- TMDX $55.00
- 52 Week High
- SID $3.08
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- SID 43.57
- TMDX 47.03
- Support Level
- SID $1.65
- TMDX $65.90
- Resistance Level
- SID $1.71
- TMDX $73.59
- Average True Range (ATR)
- SID 0.06
- TMDX 3.50
- MACD
- SID -0.02
- TMDX 0.08
- Stochastic Oscillator
- SID 3.85
- TMDX 32.78
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.